Catalysts for Teva Pharmaceuticals USA Inc
453 tracked
Mar 21, 2024
approval
FLUOROURACIL — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 14, 2024
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2024
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 4, 2024
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
FENTANYL CITRATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
FENTORA (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
ACTIQ (FENTANYL CITRATE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 15, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 6, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 6, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 6, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 6, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 4, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Dec 4, 2023
approval
MORPHINE SULFATE — FDA approval
Teva Pharmaceuticals USA Inc
→
Nov 29, 2023
approval
ALVAIZ (ELTROMBOPAG CHOLINE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Sep 29, 2023
approval
NIZORAL ANTI-DANDRUFF (KETOCONAZOLE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 26, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Jun 26, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 24, 2023
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→
Mar 24, 2023
approval
CLARAVIS (ISOTRETINOIN) — FDA approval
Teva Pharmaceuticals USA Inc
→